CD8A and neoplasm: This metabolic shift in CD8+ tumour-infiltrating lymphocytes impairs cytotoxic anti-tumour activity and effector function, reflected by increased surface expression of the immune checkpoint receptors PD-1 and TIM-3, classical markers of T-cell exhaustion (figure 2c).